Sonim FY2023 revenue rises 34% to $93.6M; net loss narrows to $90K

DNA X, Inc.

Net revenues $93.6M, +34% YoY from $69.8M in 2022.
GAAP net loss improved to $90K from $14.1M loss; Adj. EBITDA positive $4.0M.
Cash and equivalents $9.4M at year-end; 13 new carrier awards to drive 2024 sales.
Expanding into rugged pro, connected solutions, and consumer durable markets plus Europe.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

DNA X, Inc. reported the fiscal year ended December 31, 2023 results: revenue $93.6 million, net income $90 thousand.

Period: the fiscal year ended December 31, 2023
Revenue: $93.6 million
Net income: $90 thousand
Result: reported results

Exact text from the filing

Full Year 2023 and Recent Highlights ● Net revenues increased by 34% year-over-year, to $93.6 million, up from $69.8 million in 2022 ● GAAP net loss for the full year improved to $90 thousand, down from a net loss of $14.1 million in 2022

View on SEC.gov

326 earnings releases filed in the last 30 days. Browse all earnings releases →

DNA X, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-011543

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.